AbCellera Biologics, Inc. (ABCL)
11.94
-0.52
(-4.17%)
USD |
NASDAQ |
Nov 11, 16:00
11.97
+0.03
(+0.25%)
After-Hours: 17:44
AbCellera Biologics Total Liabilities (Quarterly) : 257.09M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 257.09M |
| June 30, 2026 | 233.30M |
| March 31, 2026 | 192.92M |
| December 31, 2025 | 215.59M |
| September 30, 2025 | 222.84M |
| June 30, 2025 | 227.45M |
| March 31, 2025 | 164.03M |
| December 31, 2024 | 154.58M |
| September 30, 2024 | 172.69M |
| June 30, 2024 | 177.33M |
| March 31, 2024 | 222.60M |
| December 31, 2023 | 239.86M |
| September 30, 2023 | 329.42M |
| Date | Value |
|---|---|
| June 30, 2023 | 342.34M |
| March 31, 2023 | 289.42M |
| December 31, 2022 | 307.63M |
| September 30, 2022 | 302.24M |
| June 30, 2022 | 380.93M |
| March 31, 2022 | 384.78M |
| December 31, 2021 | 292.84M |
| September 30, 2021 | 219.34M |
| June 30, 2021 | 184.18M |
| March 31, 2021 | 171.40M |
| December 31, 2020 | 175.03M |
| September 30, 2020 | 53.15M |
| June 30, 2020 | 64.32M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| MindWalk Holdings Corp. | 7.422M |
| Agilent Technologies, Inc. | 6.604B |
| Bio-Rad Laboratories, Inc. | 3.180B |
| Bruker Corp. | 3.485B |
| Azenta, Inc. | 366.08M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.500B |
| Shareholders Equity (Quarterly) | 1.062B |
| Debt to Equity Ratio | 0.126 |
| Current Ratio | 12.43 |
| Net Debt Paydown Yield | 0.03% |